Archive

Treatment of Vitreomacular Traction with Intravitreal Injection of Perfluoropropane Journal > /en/journal/2019/4/2
Purpose: To evaluate the effect of one intravitreal injection of expansive gas in the treatment of vitreomacular traction (VMT). Method: Retrospective evaluation of results of treatment of VMT with the aid of a single intraocular application of 0.3 ml 100% C3F8 gas. The procedure was performed in outpatient treatment under topical anaesthesia. Results: Twelve patients (14 eyes) underwent pneumatic...
Assessment of the Efficacy of Photodynamic Therapy in Patients with Chronic Central Serous Chorioretinopathy Journal > /en/journal/2019/6/2
Purpose: The aim of this prospective clinical study was to evaluate the anatomical and functional results of the treatment of 54 eyes with chronic form of central serous chorioretinopathy (CSC) using photodynamic therapy in a reduced (half) verteporfin (HD-PDT) dosing regimen. Materials and Methods: Our prospective study included 54 eyes of 52 patients (40 males, 12 females) at an average age of 5...
Aflibercept for Vascularised Serous Pigment Epithelial Detachment: One-Year Anatomical and Functional Results Journal > /en/journal/2020/2/5
Purpose: To assess the effect of intravitreal aflibercept on pigment epithelial detachment (PED) secondary to occult choroidal neovascularization (CNV) in treatment-naive patients. Patients and methods: Retrospective analysis of thirty-six patients (thirty-eight eyes) with mean age 77 (SD ± 7), who were treated with aflibercept 2.0 mg (Eylea, Bayer) at the Department of Ophthalmology of 1st Facult...
Retrospective Analysis Of The Presence Of Choroidal Neovascularisation Using Optical Coherence Tomography Angiography In The Treatment Of Chronic Central Serous Chorioretinopathy With The Aid Of Photodynamic Therapy Journal > /en/journal/2021/3/2
Purpose: Analysis of the presence of choroidal neovascularization (CNV) by optical coherence tomography angiography (OCTA) in eyes treated with photodynamic therapy in a reduced dosing regimen (HD-PDT, half dose of verteporfin) for the chronic form of central serous chorioretinopathy (cCSC). Materials and methods: Retrospective evaluation of OCTA findings in 54 eyes of 52 patients treated for cCSC...
Diabetic Macular Edema – Diagnostics and Treatment Guidelines Journal > /en/journal/2023/5/2
Together with diabetic retinopathy, diabetic macular edema (DME) ranks among the most common causes of severe loss of vision in working adults. Due to recent developments in imaging methods, new classification schemes of DME have been created. In addition to this, new treatment options have been introduced (new intravitreal drugs as well as treatment protocols). At the same time laser, surgical as...
Diabetic Retinopathy – Diagnostics and Treatment Guidelines Journal > /en/journal/2023/5/3
Diabetic retinopathy is one of the most common complications of diabetes mellitus and represents a serious health, social and economic problem. With the expected increase in the number of patients with diabetes, it is becoming the leading cause of severe vision loss in the working-age population. The presented guidelines summarize the current knowledge about this disease in order to standardize an...
Diabetic Retinopathy and Diabetic Macular Edema – Screening Journal > /en/journal/2023/5/4
Diabetic retinopathy (DR) and diabetic macular edema (DME) are leading causes of severe visual loss in the working population. Therefore, both DR and DME have a significant socioeconomic and health impact, which taking into account the epidemiologic predictions is expected to increase. A crucial role in the management of DR and DME (not only for individuals, but also for the population) is played ...